2nd Quarter - Report
MEHLMAN CONSULTING, INC. for VIZIENT INC
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
340b drug pricing program. Issues related to pharmacy benefit manager reform. Health care workforce. Health care supply chain. Health care drug shortages. Pandemic All-Hazard Preparedness Act Reauthorization. The Stop Drug Shortages Act (No Bill Number) discussion draft. H.R. 3008 - The Drug Shortage Prevention Act. H.R. 3810 - The Drug Origin Transparency Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| ALYENE MLINAR | — |
| DEAN ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.